Correct Answer: D. Adrenocorticotropic hormone
The clinical presentation—infantile spasms (flexor jerks of limbs toward the body), developmental regression, and hypsarrhythmia on EEG—is pathognomonic for West syndrome. Hypsarrhythmia is the hallmark EEG finding: chaotic, high-amplitude, disorganized background activity with multifocal spikes and waves. West syndrome is an age-specific epileptic encephalopathy occurring between 3–12 months of age, with infantile spasms (also called salaam seizures or jackknife seizures) as the cardinal motor manifestation. The prognosis depends critically on early recognition and prompt treatment. ACTH (adrenocorticotropic hormone) is the gold-standard first-line treatment for West syndrome, with response rates of 60–90% in idiopathic cases. ACTH works via immunomodulation and suppression of abnormal neuronal synchronization; the exact mechanism remains incompletely understood but involves cortisol-mediated effects on GABAergic and glutamatergic neurotransmission. In India, ACTH (synthetic or natural) is the standard DOC per IAP guidelines and NEET curriculum. Vigabatrin is an alternative in tuberous sclerosis-associated West syndrome. Traditional anticonvulsants like phenobarbitone and phenytoin are ineffective for infantile spasms and are no longer recommended as monotherapy for this condition.
Why the other options are wrong
A. Phenobarbitone — Although phenobarbitone is a broad-spectrum anticonvulsant used in many pediatric seizure disorders, it is ineffective for infantile spasms and West syndrome. This is a critical distinction in pediatric neurology: traditional anticonvulsants do not address the underlying pathophysiology of West syndrome. Phenobarbitone may even worsen developmental outcomes. NBE traps students who confuse West syndrome with other infantile seizure types. B. Levetiracetam — Levetiracetam is a modern anticonvulsant with a favorable safety profile, but it is not first-line for West syndrome. While it may be used as adjunctive therapy or in refractory cases, it lacks the immunomodulatory properties of ACTH that are critical for halting the infantile spasm-encephalopathy cycle. Levetiracetam is more effective in other pediatric seizure types (focal seizures, myoclonic seizures). C. Phenytoin — Phenytoin, like phenobarbitone, is a classical anticonvulsant that is ineffective for infantile spasms. It does not suppress hypsarrhythmia or halt developmental regression in West syndrome. Phenytoin's mechanism (sodium channel blockade) does not address the underlying neuronal hyperexcitability and abnormal synchronization seen in West syndrome. This is a common NEET trap pairing traditional anticonvulsants with infantile seizures.
High-Yield Facts
- West syndrome = infantile spasms + hypsarrhythmia on EEG + developmental regression, peak onset 3–12 months.
- Hypsarrhythmia = chaotic, high-amplitude, disorganized EEG background with multifocal spikes; pathognomonic for West syndrome.
- ACTH is the gold-standard first-line DOC for West syndrome with 60–90% response rate in idiopathic cases; works via immunomodulation.
- Infantile spasms (salaam seizures) = brief, symmetric flexor jerks of limbs and trunk, often in clusters upon waking.
- Vigabatrin is the preferred alternative in tuberous sclerosis-associated West syndrome; ACTH is first-line in idiopathic cases.
- Traditional anticonvulsants (phenobarbitone, phenytoin) are ineffective for West syndrome and may worsen neurodevelopmental outcomes.
Mnemonics
WEST = West syndrome Essentials West syndrome (infantile spasms), EEG shows hypsarrhythmia, Salaam seizures (flexor jerks), Treat with ACTH. Use this to recall the triad of clinical features and the DOC in one memory unit. ACTH for Spasms, Not Seizures Infantile spasms (West) → ACTH; other infantile seizures → anticonvulsants. The key discriminator is the spasm phenotype + hypsarrhythmia, not just 'seizure in an infant.'
NBE Trap
NBE pairs West syndrome with traditional anticonvulsants (phenobarbitone, phenytoin) to trap students who default to 'anticonvulsant for seizure' logic without recognizing that infantile spasms require immunomodulatory therapy (ACTH), not conventional seizure suppression.
Clinical Pearl
In Indian pediatric practice, delayed recognition of West syndrome and inappropriate use of phenobarbitone or phenytoin leads to continued developmental regression and poor long-term neurodevelopmental outcomes. Early ACTH initiation within weeks of symptom onset is critical for seizure control and developmental preservation; this is why hypsarrhythmia on EEG in an infant with spasms is a medical emergency requiring urgent referral to a pediatric neurologist.
_Reference: OP Ghai Pediatrics Ch. 10 (Neurology); IAP Guidelines on Infantile Spasms; Harrison Ch. 369 (Seizures and Epilepsy)_